hepatic arterial infusion with floxuridine(English)
- liver metastases, either synchronous or metachronous, develop in more than half of patients with colorectal cancer. Genomic risk groups identified by somatic mutation testing of colorectal liver metastasis (CRLM) can be used for “molecularly-guided” selection for adjuvant systemic chemotherapy and hepatic artery infusion of FUDR
- CRLM, EGFR, RAF, RAS, SMAD4
- Liver disease, Genomics, Chemotherapy, Oncology
- https://doi.org…000000000005315